- Oops!Something went wrong.Please try again later.
Total Voting Rights and Block Admission Return
30 June 2021
(“IQE” or the “Company”)
Total Voting Rights
As at 30 June 2021, the Company’s issued share capital consisted of 801,323,594 ordinary shares of 1 pence each (“Ordinary Shares”). All of these Ordinary Shares carry voting rights of one vote per Ordinary Share. The Company holds 4,115 Ordinary Shares in treasury.
The total number of voting rights in the Company is therefore 801,319,479. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Block Admission Return
The Company hereby provides an update to its block admission filed on 30 June 2021.
Name of company:
Name of scheme:
All employee share option plan
Period of return:
1 January 2021 to 30 June 2021
Number of Ordinary Shares not issued under scheme at the end of the last period:
Number of Ordinary Shares issued under scheme during period:
Number of Ordinary Shares cancelled under the scheme during period:
Number of Ordinary Shares added to the scheme during period:
Balance of Ordinary Shares under scheme not yet issued at end of period:
Number and class of Ordinary Shares originally admitted under scheme and the date of admission:
1,000,000 Ordinary Shares (4 Dec 2009)
+44 (0) 29 2083 9400
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Citigroup Global Markets Limited (Joint Broker)
+44 (0) 20 7986 4000
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
global telecoms infrastructure
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with c. 660 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.